Latest News
Cure SMA Awards $150,000 to Drs. Hua and Krainer at CSHL to Investigate Antisense Oligonucleotides for Spinal Muscular Atrophy
Originally published on August 8, 2013. Cure SMA is dedicated to creating a treatment and cure for spinal muscular atrophy by funding and advancing a comprehensive research program, including drug […]
Read More ›2015 SMA Researcher Meeting Summary: SMN Partners and Targets, Part 1
We will be posting a series of summaries from our 2015 researcher meeting, highlighting some of the most interesting new developments and discoveries presented there. This update covers a session […]
Read More ›PTC Therapeutics Announces Selection of a Drug Development Candidate for Spinal Muscular Atrophy
Originally published on August 9, 2013. PTC Therapeutics, Inc. (NASDAQ:PTCT) announced on August 8 the selection of a development candidate in its spinal muscular atrophy (SMA) collaboration with Roche and […]
Read More ›Meet Newly Funded Cure SMA Researcher: Dr. Adrian Krainer
Originally published on August 15, 2013. Dr. Krainer is a Professor at Cold Spring Harbor Laboratory, a member of the Cure SMA Scientific Advisory Board, and a long-term collaborator of […]
Read More ›Meet Newly Funded Cure SMA Researcher: Dr. Yimin Hua
Originally published on August 22, 2013. Dr. Hua is a Research Investigator at Cold Spring Harbor Laboratory in the laboratory of Dr. Adrian Krainer. He is a long-term collaborator of […]
Read More ›Cure SMA Scientific Advisory Board Highlights Findings from The 2013 SMA Research Group Meeting
Originally published on August 28, 2013. The Cure SMA Scientific Advisory Board (SAB) helps organize, select the content, and chair sessions at the Cure SMA Research Group Meeting. Our SAB […]
Read More ›